Self-renewal of murine embryonic stem cells is supported by the serine/threonine kinases Pim-1 and Pim-3

Stem Cells

Volumn 25, Issue 12, 2007, Pages 2996-3004

  Aksoy, Ir̀ene ^a,b,c   Sakabedoyan, Caline ^a,b,c   Bourillot, Pierre Yves ^a,b,c   Malashicheva, Anna B ^a,b,c   Mancip, Jimmy ^a,b,c   Knoblauch, Kenneth ^a,b,c   Afanassieff, Marielle ^a,b,c   Savatier, Pierre ^a,b,c  

^a INSERM   (France)

^b STEM CELL AND BRAIN RESEARCH INSTITUTE   (France)

^c UNIVERSITÉ DE LYON   (France)

Author keywords

Cell cycle; Embryonic stem cells; Leukemia inhibitory factor; Pim kinases; STAT3 transcription factor

Indexed keywords

ESTROGEN RECEPTOR; GLYCOPROTEIN GP 130; GRANULOCYTE COLONY STIMULATING FACTOR; LEUKEMIA INHIBITORY FACTOR; PROTEIN KINASE PIM 1; PROTEIN KINASE PIM 3; PROTEIN SERINE THREONINE KINASE; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENZYME ACTIVITY; GENE; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; PIM 1 GENE; PIM 3 GENE; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; MICE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-PIM-1;

MURINAE;

EID: 37349062460     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0066     Document Type: Article

References (34)

1. Burdon T, Chambers I, Stracey C et al. Signaling mechanisms regulating self-renewal and differentiation of pluripotent embryonic stem cells. Cells Tissues Organs 1999;165:131-143.
2. Boeuf H, Hauss C, Graeve FD et al. Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells. J Cell Biol 1997;138:1207-1217.
3. Niwa H, Burdon T, Chambers I et al. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 1998;12:2048-2060.
4. Matsuda T, Nakamura T, Nakao K et al. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J 1999;18:4261-4269.
5. Burdon T, Stracey C, Chambers I et al. Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev Biol 1999;210:30-43.
6. Duval D, Reinhardt B, Kedinger C et al. Role of suppressors of cytokine signaling (Socs) in leukemia inhibitory factor (LIF)-dependent embryonic stem cell survival. FASEB J 2000;14:1577-1584.
7. Oka M, Tagoku K, Russell TL et al. CD9 is associated with leukemia inhibitory factor-mediated maintenance of embryonic stem cells. Mol Biol Cell 2002;13:1274-1281.
8. Cartwright P, McLean C, Sheppard A et al. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 2005;132:885-896.
9. Li Y, McClintick J, Zhong L et al. Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood 2005;105:635-637.
10. Bachmann M, Moroy T. The serine/threonine kinase Pim-1. Int J Biochem Cell Biol 2005;37:726-730.
11. Allen JD, Berns A. Complementation tagging of cooperating oncogenes in knockout mice. Semin Cancer Biol 1996;7:299-306.
12. Allen JD, Verhoeven E, Domen J et al. Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc. Oncogene 1997;15:1133-1141.
13. Stout BA, Bates ME, Liu LY et al. IL-5 and granulocyte-macrophage colony-stimulating factor activate STAT3 and STAT5 and promote Pim-1 and cyclin D3 protein expression in human eosinophils. J Immunol 2004;173:6409-6417.
14. Shirogane T, Fukada T, Muller JM et al. Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. Immunity 1999;11:709-719.
15. White E. The pims and outs of survival signaling: Role for the Pim-2 protein kinase in the suppression of apoptosis by cytokines. Genes Dev 2003;17:1813-1816.
16. Adam M, Pogacic V, Bendit M et al. Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL. Cancer Res 2006;66:3828-3835.
17. Indra AK, Warot X, Brocard J et al. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: Comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res 1999;27:4324-4327.
18. Aubert J, Dunstan H, Chambers I et al. Functional gene screening in embryonic stem cells implicates Wnt antagonism in neural differentiation. Nat Biotechnol 2002;20:1240-1245.
19. Savatier P, Lapillonne H, van Grunsven LA et al. Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor upregulates Dtype cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells. Oncogene 1996;12:309-322.
20. Wobus AM, Wallukat G, Hescheler J. Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation 1991;48:173-182.
21. Storm MP, Bone HK, Beck CG et al. Regulation of Nanog expression by phosphoinositide 3-kinase-dependent signalling in murine embryonic stem cells. J Biol Chem 2007;282:6265-6273.
22. Paling NR, Wheadon H, Bone HK et al. Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signalling. J Biol Chem 2004;279:48063-48070.
23. Nichols J, Zevnik B, Anastassiadis K et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998;95:379-391.
24. Mochizuki T, Kitanaka C, Noguchi K et al. Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway. J Biol Chem 1999;274:18659-18666.
25. Vallier L, Mancip J, Markossian S et al. An efficient system for conditional gene expression in embryonic stem cells and in their in vitro and in vivo differentiated derivatives. Proc Natl Acad Sci U S A 2001;98:2467-2472.
26. Shi W, Wang H, Pan G et al. Regulation of the pluripotency marker rex-1 by Nanog and Sox2. J Biol Chem 2006;281:23319-23325.
27. Qu CK, Feng GS. Shp-2 has a positive regulatory role in ES cell differentiation and proliferation. Oncogene 1998;17:433-439.
28. Anneren C, Cowan CA, Melton DA. The Src family of tyrosine kinases is important for embryonic stem cell self-renewal. J Biol Chem 2004;279:31590- 31598.
29. Loh YH, Wu Q, Chew JL et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006;38:431-440.
30. Galaktionov K, Chen X, Beach D. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 1996;382:511-517.
31. Bartek J, Lukas J. Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol 2001;13:738-747.
32. Aho TL, Sandholm J, Peltola KJ et al. Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site. FEBS Lett 2004;571:43-49.
33. Li YY, Popivanova BK, Nagai Y et al. Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines. Cancer Res 2006;66:6741-6747.
34. Duval D, Trouillas M, Thibault C et al. Apoptosis and differentiation commitment: Novel insights revealed by gene profiling studies in mouse embryonic stem cells. Cell Death Differ 2006;13:564-575.